IDN-5390

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameIDN-5390
Drug Alias Name14-OH DABpaclitaxel derivatives (Indena)IDN-5868IDN-5869IDN-6140 +[6] 
ClassificationBiologics
Mechanisms of ActionAngiogenesis inhibitorsMicrotubule stabilizerTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIndena Spa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndena SpaTorii Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A